common.study.topics.clinical

Single Dose Truvada Study

common.study.values.description

Single Dose Truvada Study

This study examines tenofovir (TFV) drug concentrations in adults one day after taking a single dose of TruvadaAR - a pill used to prevent and treat HIV infection. The results of this study will be used to improve the (efficacy/accuracy) of a white coat adherence (WCA) detection test - a blood test that can be used to indicate medication adherence. Participants will receive one dose of TruvadaAR, and provide 2 total samples of blood.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Tenofovir

pre- and post-dosing measurements of TFV and TFV-DP in plasma and PBMCs.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Single Observed Dose Administration of Truvada® to Establish Single Dose Pharmacokinetic Standards in Healthy Individuals

common.study.values.clinical-trial-id

NCT03719053

participant.views.study.view.id

av2jra